Markets open

IQVIA Holdings, Inc.

IQV · NYSE

Analyst Consensus

Buy

17 analysts

$235

Current

—

Low

$275

Average

—

High

Average target implies +16.80% versus the current price.

The ratings synthesis for IQV has not been generated yet.

Rating Actions

No individual rating actions have been captured for IQVyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

B OF A GLBL RES

BAIRD R W

BARCLAYS CAPITA

CITIGROUP

DEUTSCHE BK SEC

EVERCORE ISI

GUGGENHEIM SEC.

HSBC GLOBAL RES

JEFFERIES & CO.

JP MORGAN SECUR

MIZUHO SECURITI

MORGAN STANLEY

STIFEL NICOLAUS

TD COWEN

TRUIST SECURITI

WILLIAM BLAIR

ZACKS RESEARCH

Symbol: IQV
Type: Stock
Sector: Health Care
Industry: Biotechnology: Commercial Physical & Biological Resarch
Country: North America
Exchange: NYSE

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.